EverSource Wealth Advisors’s Alamar Biosciences ALMR Stock Holding History

EverSource Wealth Advisors’s Portfolio ALMR Stock Details ALMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$34	Buy	+1	New	+$29	﹤0.01%	4478

Other funds holding ALMR

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

IEQ Capital Foster City, California $23.5B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dymon Asia Capital (Singapore) Singapore $2.21B AUM 109.09% 1-Year Est. Return

EverSource Wealth Advisors's ALMR Position: Q3 2026 in Review

EverSource Wealth Advisors opened a new position in Alamar Biosciences (ALMR) in Q3 2026: 1 share worth $34. The stake represents ﹤0.01% of the portfolio and ranks #4478 among its holdings.

35 funds tracked by Wall St. Rank hold ALMR as of Q3 2026.

EverSource Wealth Advisors held 1 share of Alamar Biosciences worth $34 as of Q3 2026.
Alamar Biosciences was a new EverSource Wealth Advisors position in Q3 2026.
Alamar Biosciences made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q3 2026, its #4478 holding.
35 funds tracked by Wall St. Rank held Alamar Biosciences as of Q3 2026.

Based on EverSource Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.